Sustained-release version of BPH drug deemed approvable

Article

The FDA issued an approvable letter for a sustained-release formulation of doxazosin mesylate (Cardura XL), an alpha-blocker used to treat BPH.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.